Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Regis Healthcare Ltd. (REG) vs. Competitors

27 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
AU:REGRegis Healthcare Ltd.AUD 4.62AUD 1.44B25.03-36.10%Moderate BuyUnlock the AU:REG analyst price target with TipRanks PremiumAU:REGUnlock the AU:REG top-analyst price target with TipRanks Premium
AU:EPNEpsilon Healthcare LimitedAUD 0.02AUD 9.73M76.67-4.17%―Unlock the AU:EPN analyst price target with TipRanks PremiumAU:REG vs AU:EPNUnlock the AU:EPN top-analyst price target with TipRanks Premium
AU:HLSHealius LimitedAUD 0.59AUD 439.34M-1.03-37.23%HoldUnlock the AU:HLS analyst price target with TipRanks PremiumAU:REG vs AU:HLSUnlock the AU:HLS top-analyst price target with TipRanks Premium
AU:RHCRamsay Health CareAUD 53.90AUD 12.50B39.6369.50%HoldUnlock the AU:RHC analyst price target with TipRanks PremiumAU:REG vs AU:RHCUnlock the AU:RHC top-analyst price target with TipRanks Premium
AU:AHCAustco Healthcare LimitedAUD 0.28AUD 103.06M11.57-31.71%Moderate BuyUnlock the AU:AHC analyst price target with TipRanks PremiumAU:REG vs AU:AHCUnlock the AU:AHC top-analyst price target with TipRanks Premium
AU:SHLSonic Healthcare LimitedAUD 21.65AUD 10.54B17.60-5.21%HoldUnlock the AU:SHL analyst price target with TipRanks PremiumAU:REG vs AU:SHLUnlock the AU:SHL top-analyst price target with TipRanks Premium

Performance Comparison

-75%-50%-25%0%25%50%75%100%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
AU:REGRegis Healthcare Ltd.4.62-2.77-37.48%
AU:EPNEpsilon Healthcare Limited0.02-0.00-4.17%
AU:HLSHealius Limited0.59-0.30-33.71%
AU:RHCRamsay Health Care53.9023.2275.66%
AU:AHCAustco Healthcare Limited0.28-0.11-29.11%
AU:SHLSonic Healthcare Limited21.65-0.27-1.25%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts